Reglstored number: 08240913 Charlty number. 1149758 ARK CANCER CHARITY (A Company Llmltsd by Guarantse) UNAUDITED TRUSTEES. REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024
ARK CANCER CHARrrY (A Clxnpany Umlted by Guarantee CONTENTS Page Reference and Admlnlstratlve Detalls of the Company. Its Trusto05 and Advlse Trustees, Report Trustees. Rgsponslbllltles Statement Independent Examlnets Report 9-10 Statement of Flnanclal Actlvltl 11 Balance Sheet 12-13 Statoment of Cash Flows 14 Notes to the Flnanclal Statwn•nts 15-29
ARK CANCER CHARITY IA Company Llmlted by Guarantse) REFERENCE AND ADMINISTRATIVE DETAILS OF THE COMPANY, ITS TRUSTEES AND ADVISERS FOR THE YEAR ENDED 31 DECEMBER 2024 Trustee8 M Rees S Fell, Chalr R Finlayson l Harrlson Company rogl8t•Md numbor 08240913 Charfty rogl8t•rad number 1149768 Rogl•tsred offlGe The Ark Conference Centro, Dinwoodi• Drive, Ba8lng8tok8, Harnp8hlre, RG24 9NN Company 8Kretary B Devereux AOUntant8 Shaw Glbbs (Audlt) Llmlted, Wey Court Wa8t, Unlon Road, Farnham, Surrey, GU9 7PT Page 1
ARK CANCER CHARITY (A Company UM1t by Guarants•) TRUSTEES, REPORT FOR THE YEAR ENDED 31 DECEMBER 2024 The Truslee8 (who are al80 diredors of the Charity for the purposes of the Compan188 Act) present their annual report, which is also the directors, report. togethor wilh th8 financial statements of Ark Cancer Charity (the Company) for the year ended 31 December 2024. The Trustees ¢onfinn that the Annual Report and Financial Statements of the company compty vfith the current ststulory requirements, the requirements of the companys goveming document and the provisions of the Statement ol Recommended Practlce (SORP) "Accounting and Reportlng by Charities. (effective 1 January 2019). Sinca the Company qua1ffi68 as small under sectlon 383. the Strateglc Report requlred of medium and large companles under the Companies Act 2006 (Strategic Report and Directors, Report) Regulatlons 2013 16 not required. 8tvucturn, manag•mt and 9ov•rnanc• • 8tructur• Ark Cancer Charity 18 a Company Limited by Guarantee (No: 8240913) and a Charity Registered In England and Wale8 {No: 1149758). It is govemed by its Memorandum and Article8 of A880ciatlon. The Trustee8 constitute Directorn of the Charity for the purp08es of company law. Ark Cancer wa8 registered a8 a cwipary on 4th October 2012. It was registered as a charfty on 14th Novomber 2012. Emphas18 18 pla¢8d the 8ki118 of the TnMtees to ensur• TN$tees' full contrlbullon to the ChaTty8 development. • Managofflont The management of the Charlty fall8 into three areas of re8ponsibilty: The managernent of th• Charity are d•dlcated to enhanc8 the experi¢0 of wicer patients fecoivlng treatment at Hamp8hire Hospital Foundatson TnwL Thr(wh the grants pollcy, we ero able lo fund the Wellbdng Service which the NHS Vrnnty canrKJt provlde. Communication: The Tru8tee8 wll ensure that tho alms of the Charity are proiected with aUr8¢Y and clarlty lo the general public, acro88 all fvndral6ing activitses arxl initiatives to en8ure a rdectlon of It8 objects. Finan¢• and administran. Responsibillty for the accounting, sla1. legal and administrative requirernts of t Charity are managed by the Tru8tee8. Pa98 2
ARK CANCER CHARrrY IA Company Llmlted by Guarantee) TRUSTEES. REPORT (coKfiNUED) FOR THE YEAR ENDED 31 DECEMBER 2024 StNcturn, rnanageMt and governanc• (contlnued • Governance 1. Oblectlves and Activities The Charitls objects as stated in its Artlcles of Assoclatlon are: The relief of sickness and the Preservation of health and to assist in the treatment and care of persons affected by cancer through the enhancements of all aspects of cancer care including". providing or assisting in the pr¢ESTon of equipment, facilities and Sgnfjces anclllary or supplemenlal to those provided by the statutory authorities or other care providers. to provide or assist in the provision of funding for enhanced or improved frtting out and decoration or any improvement to the aesthetic aspects of new or existing cancer care centres run by the statutory authoritles or other care provlders to enhance the wellbeing of persons affected by cancer. provlding or assisting in the provision of. or provKling funding for statutory authorities or other care providers to provide, ancillary and Complementary care SeICe8 and therapies to enhance the wellbeing of porsong affected by cancer. provide support assistance and infomiation directly or indirectly to peopk affected by cancer and their carer8, famil and friends. promote and influence effective care, involvement and support for people affected by cancer. their rs, families and friends. The furtherance of Such objects and purposes to be carried out in North Hampshire or generally in the United Kingdom being objects and purposes which are exclusively charitable according the law of England and Wales. 2. Publtc Benefit The Charity has looked at the public benefits of its objectives and hag concluded that there Is significant evidence highlighting that offering tr8atm8nt in a plewaant. interesting, innovative environment ben8frt5 patients and greatly improves the outcome of their treatment. The grants will ensure the provision of: Services within an exceptior1 setting %there the environment will help to elevate the psychobgical wellness of patients and their families. Evidence substantiates those administering treatments wlthin an uplifting facilty contributes positively to patients and enhances the effectiveness of thelr cancer treatment. A range of support therapies. l.e. psychological support, survivorship courses, access to heafth, fitness, ¢omplementary therapies, etc. plus comprehensive inforniation resources. These services will enable patients to manage their condition throughout diagnosis and treatsnent to assist people IlvSng %Mth canGer and their familie8. In summary the public banafft of Ark Cancer Charity is to ansura that anhanced facilities are availabla for anyona who need¥ Support, whether they are receiving treatment or are family members engaged in supporting a Sufferer during or after their treatmenL Page 3
ARK CANCER CHARITY (A Company Umltod by Guaranteo) TRUSTEES. REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 Structure, manag•m•nt and govemance {contlnued) Therefore the Trustees belteve that they have complied with the duty to have due regard to guidance published by the Charity Commission. Plans for future porlod8 To meet the increasing demand for our services, we plan to exiend the Centre's faciliti by adding additional rooms to accommodate more clinics. This expansion will allcwl us to reach more patients and provide them with the 8UPPOrt they need. • Grnnt maklng pollcy Fundlng Is made available to Harnpshiro Hospitats NHS Foundatlon Trust via grants. Grants are made to Hampshire Hospitals NHS Foundation Trust at the Trustees, discretion. The Trustees assess all bids from Hampshire Hospitals NHS Foundation Trust to ensure that the Charlty would not be subslituting other funding sources for standard NHS provision but would be contributing to enhancing what 18 expected over and above that which will be prOVed by Hampshire Hospitsls NHS Foundation Trust. Grant requests to provide integrated a¢¢ess to Complernentary therapies and support services are required to demonstrate that they meet at least one of the following objectives in order to be considered for funding: Enhancing the qualty of care receNed by patients and families over and above the NHS standard provision. Improving patient confidence in care provided. Pump priming and supportlng innovation. Supporting the development and growth of the Wellbeing Centre to enable access to more patients. Attraction, retentlon and development of staff of the hlghest calibre. Grants are not made to any other organisation or individual. Once a grant has been approved the commltment is recogni8ed and the grant is paid in agreed instslments over the duration of the proiect. F5nanclal r•vlew Investment pollcy The Charity Trustees have agreed that cash deposits should be held in fixed tem interest bearing accounts which will ensure that funds can be acxessed promptly, strategically and operationally as demands arise. In Ihe previous year, the Trustses agreed to designate £1,500,000 towards the future funding of the Wellbeing Centre. of whlch at the year end the closing balance of the fund is at £1,062,000. The Charity Trustees have also agreed to designate £1,000,000 towards the future refurbishment of the Rainbow Unit which has been expended at the year end. Page 4
ARK CANCER CHARITY (A Company Llmlted by Guarante•) TRUSTEES. REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEM8ER 2024 • Reserves pollcy At the year end the Charity held unrestricted reserv&8 of £1,324,029 (2023 - £2.655.918) of which £1,062,000 (2023 - £2,381,389) was designated by the Trustees. The Reserves Policy will be subject to an annual raview, conducted at the end of each financial year. This review will take into account the projectsd budget for the upcomlng year, allowlng the trustees to assess the adequacy of the existing reserves. Achl8voments and perforniance • Maln achlevements ot Unil During the 2020 Covid pandemic, chemothordpy treatments at Basingstoke Hospital were moved to standalone unit to ensure the safety of patients and stsff by isolating them away frorn the main hospital building. Recognising the success of this arrangement. the Ark Cancer Charity funded an extensive renovation of this un to create a more cohesive and efficient working and treatment environment. Collaborating with a team of architects, the Charty conducted a feasibility study to pkn the renovation following which the hospital appointsd an Estate Project Manager and Clinical Project Manager to oversee the project during the refurbishment process. The works took place from July to October 2024. Both staff and patients actively participated in selecting appropriate colour schemes and styles of artwork for the internal design, ensuring a thoughtful and inclusive approach to the univs aesthetics. Genharn Twst generously agreed to release the £SOO,000 of match funding previously raised through their fundraising platfomi by supportiva donors of Ark Cancer Charity. They also approved a furthw £50,000 towards the costs of the relocation of the chemotherapy unit to a temporary hom8 for the duration of the refurbishment works, having recognised our contribution to the local community and in honouring us in November 2023 wth the Health & Wellbeing Charity of the Year Award during the inaugural Greenham Trust Charty Awards Ceremony in Newbury. The charity is extremely grateful for their ongoing support. This award not only acknowledges the outstanding achievement$ of our Charity but also highlights the positive impact we have made on the communivs health and wellbein9. Wellbein Services The Ark Cancer Charitls Wellbeing Centre continues to positively impact the communty by providing much- needed 8UPPOrt 8ervices to cancer outpatients. It has become a irital communty resourcq offering complementary therapi and counselltng services at Hampshire Hospitals NHS Foundation TrusL The Centre serves a wtde range of nGer outpatients, demonstrating its abilty to cater to diverse need5. including breast, 9ynaecological, haematologlcal, prostate, colorectal, upper gastrointestinal. and lung cancer patients. This inclusivity ensures that a broad range of individuals can access tailored support. By offering ¢ornplementary therapies alongside conventional medical care, the Centre promotes healing that encompasses both physical and emotional wellbeing. Patients benefrt from a comprehensive approach that addres8e8 treatment slde effects and emotlonal challenges. Page 5
ARK CANCER CHARITY (A Company Llmlted by Guarantee) TRUSTEES, REPORT (CONTINUED) FOR THEYEAR ENDED 31 DECEM8ER2024 Achlevements and perf0mian (contlnuadl The Centre's team of experienced therapists and counsellors bring a wealth of knowladge to patient care. Thair adheren¢e to NHS guidelines and collaboration with clinical colleagues ensures that patients receive evidence- based, integrated care. By collecting and utilising patient feedback, the centre demonstrates ts commitment to putting patients at the forefront of ts services. This approach not only Improves care qualty but akn offers insights to HH clinicians regarding treatment outcom85 and patient experiences. Variou5 case studies have highlighted the Centre's therapies leading to positive outcomes such as alleviating treatrnent side effects, aiding post-operatiw recovery, and supporting patients through challenging treatments such as radiotherapy. Th8 Chartty has provided additional space within the newly refurbished chernotherapy unit for Ihese services and has increased the grants available in 2024 in line with the increa8ing demand. ilolhe Chemotherapy. a crucial part of cancer treatment, often adS to various side effects. th chemotherapy- induced peripheral neuropathy (CIPN) being a welkknown concem. This condition predominantly affects the hands and feet of cancer patients, resulting in severe pain, discomfort, tingling, numbn&ss, and balance i&8ues. The Hilotherm machine is a tailored solution designed to prevent or minimise the adverse effects of CIPN and HFS and following a successful trial at Basingstoke Hospital, we were abla to fund the purchase of a further machine at Basingstd(e, and iwo machines for the chemotherapy department at Winchester. These specffic purchases were made possible through a further generous donation by The Edwina Mountbatten and Leonora Children's Foundation who have supported thi8 project from the outget. Page 6
ARK CANCER CHARITY IA c1panY Umtted by Guaranto0> TRUSTEES. REPORT (CONTINUED) FOR THE YEAR ENOED 31 DECEMBER 2024 Achlevement8 and perft>rmance Icontlnued) Fundral8lng actlvlty over the pa•t year Throughout the year, our charity has continued 118 fundraising effort8 via online platform8 and h88 received consistent 8UPPOrt fr various communlty groups. The $0:SO initiatN8 has maintalnod Its popularity, contrlbutlng to our fundralslng 8ucce8S. In Nov•mbor 2024, recruited a Fundrnlslng Managor to increase our acbvth8s, building on all of the good work whlch has been carrled out In the pa8t 80 thai can contlnue to fund the demand for our patientntrOd wellbelng 8ervlce8. We extend our heartlelt gratit to ovoryone invowour dedlcated team Mbe. 8UPPOrtern, and the community at large. They inspire us to continue our fundraising with rentrd vwJour. knowing that our collectSve effort8 are makSng a meanlnglul difference in the INe8 of those we serve, and look fomrd to contlnuing our Journey towards creating a positlve Impact In the cL¥nmunity. Small compan188 not• In preparlng th18 report, Ihe dlrectors have taken advantag& ol tha small companios exemptlon8 provlded by section 415A of the Companies Act 2006. Approved by order of the members of the board of TNstaes and signed on thelr behalf by: 8 Fell (rrustee) %PRI( Page 7
ARK CANCER CHARITY (A Company Llmltsd by Guarantee) STATEMENT OF TRUSTEES. RESPONSIBILITIES FOR THE YEAR ENDED 31 DECEMBER 2024 The Trustees (who are also the directors of the Company for the purposes of compary law) are responsible for preparing the Trusteos, Report and the financial statements in accordance with applicabla law and United Kingdom Accountlng Standards (United Kingdom Generally Accepted Accounting Practice). Company law requires the Trustees to prepare financial statements for each financlal . Under company law. the Trustees must not approve the financial statements unl&ss they are satisfied that they give a true and fair view of the state of affairs of the Company and of ts incorning re80urces and application of rgsources, including its income and expenditure, for that period. In preparing these financial statements, the Trusteeg are required to: select suitable accounting policies and then apply them con5iStently; observe the meth(Jd5 and principles of the Charities SORP (FRS 102): make judgments and accounting estimates that are reasonable and prudent; stste whether applicable UK Accounting Standards {FRS 102) have been followed, subjact to any material departures disclosed and explained In the financial Statements; prepare the financial statements on the going concem basis unless it is inappropriate to presume that the Carnpany will continue in business. The Trustees are responsible for keeping adequate accounting records that are sufficient lo Sh and explain Ihe Companys trdnsactions and disclose with reasonable accuracy at any time the financial posstion of the Company and enable them to ensu that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the Company and hence for taking reasonable steps for the prevention and detection of fraud and other Iularities. Approved by order of the rnanbers of the board of Trustees and 8igned on its behalf by: S Fell (Trustee) Date: 2tfA[I Page 8
ARK CANCER CHARITY (A Company UM1t by Guaranteo) INDEPENDEKf EXAMINER'S REPORT FOR THE YEAR ENDED 31 DECEMBER 2024 Independont Examlnots Report to the of Ark Cancer Charlty (Ihe Comparf) I report to the charity Trustees on my examination of the accounts of the C(Thpany for the year ended 31 December 2024. Responsibiliti88 and 8asls of Report A5 the Trustees of the Company (and ts director3 for the purposes of company knw) you are responsible for the preparation of the accounts in accordance TMlh the requirentS of the Companies Act 2006 (Ihe 2006 Acr). Having satisfied myself that the accounts of the Cmipany are not required to be audited under Part 16 of the 2006 Act and are etigible for independent examinatKJn. I report in respect of my examination of the Companls accounts carriad out undef section 145 of the Charities Act 2011 ('the 2011 Act,). In ¢arying out my examination I have folkmpd the Diredons given ty the Charity Commi&8ion under 8ection 145(5)(b) of the 2011 ACL Indep•nd•nt Examlnerfs Statsment Since the Companls grw incoma exce•Jed £250.000 your examiner must be a member of a body listed in section 145 of the 2011 ACL I confirm that l am qualified to undertake the &Yaminalion because l am a member of (enter body here). which is one of ts listed dia6. I have completed my examination. I confirm that no matters have come to my attention in connection with the examination gmng me cause to believe: accounting records were not kept in res of the Ccynpany as required by section 386 of the 2006 kt: or the accounts do not accord Mth those records; or the accounts do not comply the accounting requirwnents of section 396 of the 2006 Act other than any requir8m&tt that the accounts give a Irue and fairf view which is not a m*ter considered as part of an independent examinatNM; or the accounts have not been prepared in accordance with the methods and prfnclth of the Statemenl of Recommended Practice for accounting and reporting by ¢harthes [appli¢able to ¢harities pparing their accounts in accordance wlh the Financial Rewtng Standard appkable in tho UK and Repubkc of Ireland (FRS 102)]. I have no concerns and have come across other matters in connection with the examinati¢)n to which attention should be drawn in this rw in order to enable a proper understanding of Ihe Kcounts to be reached. Page 9
(A Company Llmlted by Guarantoo) INDEPENDENT EXAMINER'S REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 This report is made solely to the Companls Tntstees, as a body, in accordance with Part 4 of the Charities (Accourrts and Reports) Regulations 2008. My work has been undertaken so that I might state to the CompanWs Trustees those matters l am required to state to them in an Independent Examiners Report and for no other purpose. To the fullest extent permitted by law, I do not a¢c8pt or assum8 responsiblfjty lo anyone other than the Company and the Companrfs Trustees as a body, for my w>rk or for thi8 reporL Signed: Mark DkinSOn (FCA) Shaw Glbbs IAudlt) Llmlted Wey Court West Union Road Famham Surrey GU9 7PT Page 10
ARK CANCER CHARITY (A Company Llmltad by Guarantee) STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING INCOME AND EXPENDITURE ACCOUNT) FOR THE YEAR ENDED 31 DECEMBER 2024 Unrestrfcted funds 2024 Total funds 2024 Total fund8 2023 Note In¢omo from: Donatlon8 and legacies Other trading activitles Investments 688,736 34.817 82,266 888,738 34.817 82,266 37.415 30,075 69,541 Total Income 805.819 805.819 137,03t Exp•ndlturo on: Raising fund8 Charltable 8Ctlvltla8 3.809 2,134.100 3,809 2.134.100 2,614 139,087 Total oxpendltur• 2,137.709 2.137.709 141,701 N•t movem•nt In fund• (1,331.8901 (1,331.890) (4,670) Reconclllatlon of funds: Total fund8 brought foMrd Net mowment in fund8 2,655,918 2.656,918 11,331.890) (1.331.890) 2,660,588 (4, 670) Total funds caffted fomard 1,324,028 1.324.028 2,655,918 The notes on Pag 15 to 29 form part of these financial statements. Page11
ARK CANCER CHARITY (A Company Llmited by Guarante•) REGISTERED NUMBER: 08240913 BALANCE SHEET ASAT 31 DECEMBER2024 2024 2023 Not• Flxed a88ets Tanglble a88ets Curr•nt aMots 11 8,341 7,010 Debtor8 Inv88tment8 Cash at bank and In hand 12 13 681,676 1,000,000 I,B39,914 9,838 2,058,596 677,932 3,121,690 Z 746,366 Crgditor8: amount8 falllng due thIn on8 14 (1,805,902) (97,458) Not currnnt a88et• 1.316.688 2,648,908 Total not amet• 1.324.029 2,655,918 Charlty funds Unrestrlcted fund8: Wellbeing complimentary theraple8 Wellbeing mental health 8ervic88 Rainb1 unlt project General furHIs 15 15 15 15 366,000 696,000 366,000 623,634 1,391, 755 274.529 262.029 Total unrestrlctod fund8 15 1.324.029 2,655,918 Total fund8 1.324.029 2,655,918 Page 12
ARK CANCER CtrIARITY (A Company Llmlted by Guarantee) REGISTERED NUMBER: 08240913 BALANCE SHEET (CONTINUED) AS AT 31 DECEMBER2024 The Compary wa8 antittad to exemption from audit under section 477 of th& Compan188 Act 2006. The members have not required the Gompany to obtain an audit for the year In questlon In accordance wlth 8edion 476 of Companies Act 2006. Tha Tru8tee8 acknowledge their re8pon8ibilitie8 for comptying wlth the requiremen18 of the Act wrth re8pe¢t to accountlng records and preparation of financial 8tatements. The flnanclal statement8 have been prepared in accordance wlth the provl8lon8 appllcabla to entit588 subject to the small compani08 reglme. The Ilnanclal statement8 were approved and author58ed for188ue by the Tru8tee8 and 61gned on thelr behalf by.. 8 F911 Tru81e8 blq12& The note8 on paga8 1 S to 291orni part of the88 flnanclal statements. Page 13
ARK CANCER CHARITY (A Company Umlted by Guarantee STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 31 DECEMBER 2024 2024 2023 Cash flow8 operatlng actlvftle• Net cash used In operatlng acttvlttes 18 (276.61n (160,200J Cuh flow8 from Invmtlng actlvltl Pur¢ha8e of tangible fixed assets (3,263 (6,335J Net ca•h u•od In Inv•8tlng actlvltl•8 (3,263 (6,336) Cash flow• from Ilnanclng actlvlti Dlvidends, Interest and rent8 from investment8 B1266 69,541 Not ca•h provlded by flnanclng aciivltles 82.286 69.641 Chango In ¢a•h and ca•h ¢qulv•lonts In th• y•ar Cash and cash equwents at Ihe beginning of the y•ar (196,614 2.736,628 (96.994) 2,833,522 Cash and cash equlvalents at tho •nd ol th• YMI 19 1639,914 2, 736,528 The note8 on pages 15 to 29 form part of these financlal statements Page 14
ARK CANCER CHARITY (A Company Llmltsd by Guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 G•norn1 Infomiatlon Ark Cancer Charity 18 a private company, limited by guarantee without share capilal and incorporated in England. Its reglstered office address 18 The Ark Conference Centre, Dinwoodie Drive, Ba8ingstoke, Hampshire, RG24 9NN. Accountlng pollcl 2.1 8a818 ol preparntlon of flnanclal 8tatsm•nts The financial 8tatemant8 have ba8n prepared In accordance wlth the Charttle8 SORP {FRS 102) - Accounting and Reporting by Charities: Statement of Recornmended Practlce applScable to charitles preparlng their account8 In accordance wlth the FlnancSal Reporting Slandard appllcable in the UK and Republlc of Ireland (FRS 102) (effective 1 January 2019), the Financlal Reporting Standard applicable In the UK and Republic of Ireland (FRS 102) and the Companies Act 2006. Ark Cancer Char]ty meets the definition of a public benefit entity under FRS 102. Assets and liabilities are Inltlally recognl8ad at historical c08t or transaction value unless otherwlse stated in the relevant accounting policy. 2.2 Incomo All Income 18 recogn18ed once the Company ha8 entitlement to tho Incorne, It Is probable that the income WEII be recelved and the amount of Income receivable can b? measured rellably. The recognition of Incomo from legacle818 dependent on e8tabli8hing entitlement, the probabilty of recelpt and the abllSty to estimate w5th suffident accuracy the amount recelvable. Evidence of entldament to a legacy exlsts when the Company ha8 8uffi¢Sent avldanca that a glft has been laft to them (through knowledge of the exSstenGe of a valid will and the death of the benefactor) and the executor is 8at18fied that the property in que8tion will not be required to Satisfy claims In the e8tate. Receipt of a legacy must be recognls8d when It18 probable that It will be recelved and the fair value of the amount recelvable, whlch wlll ganerally be the expected cash amount to be dlstributed to the Company, Can be reliably measured. Grants are Included In the Statemant of Flnancial Actlvltle8 on a recalvable basls. The balance of Income received for 8peGific purposes but not expended during the perfod 18 shown in the relevant funds on the Balance Sheet. Where income 18 received in advance of entitlement of receipt, its recognttlon 58 deferred and included In creditors as deferred Income. Where entiuement occurs before income is received, the income is aGGrued. Donated seNlces or facilttles are recognlsed when the Company has Mntrol over the Item, any conditions a88ociated with th& donated item have been met, the receipt of economic benefit from the Use of the Company of the Item Is probable and that economlc benefrt can be measured rellably. In accordance with the Charities SORP (FRS 102), general volunteer time Is not recognised and refer to the Trust8•8' report for more infomiation about their contribution. On rKelpt, donated profe88ional services and facilities are recogni8ed on the ba818 of the value of the gift to the Company which 1$ the amount it would have been I111n9 to pay to ¢)btain $8rvicas or facilities of equivalent ewnomic benefrt on the open markel; a corresponding amount 18 then reGognisad in expanditura in the period of receipL Income tsx recoverable in relation to inve8tment income is recogni8ed at the time the investment income is receivable. Page 15
ARK CANCER CHARITY (A Company Llmlted by Guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 Accounting poll¢l8s (contlnued) 13 Expendlture Expendtture is recognised once there is a legal or constructive obligation to transfer e¢onomic benefrt to a third party, it is probable that a transfer of economic benefts will ba required in settlement and the amount of the obligation can ba measured reliably. Expenditurè is classified by actlvity. The costs of e8ch activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributable to a single activty ara allocated direcdy to that activity. Shared costs which contribute to more than one activty and support costs which are not attributable to a single activity are apportioned between those activitles on a basis consistent with the use of resources. Central staff costs are allocated on the basis of time Spent, and depreciation charges allocated on the portion of the asset's use. Expenditure on raising funds includes all expenditure incurred by the Company to raise funds for ts charitable purposes and includes costs of all fundraising a¢tiviti8s events and non-charitable trading. Expenditure on charitable activities is incurred on directly undertaking the actSvities which further the Companls oW"ectives, as 11 as any aSslated support Costs. Grants payabla are charged in the year when the offer is made exc8pI in those cases whara the offer is conditional, such grants being recognised as expandlture when the conditions attaching are fulfilled. Grants cffered subject to conditions whiGh have not been met at the year end are noted as a commitment. but nat accrued as expenditure. All expenditure is inclusive of irrecoverable VAT. 2.4 Internst recelvable Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the Company, this is noMial upon notification of the interest paid or payable by the institution with whom the funds are deposited. 2.5 Tanglbla flxod assets and depreclatlon Tangible red assets are initsalty recognised at cost. After recognition, under the cost rnodel, tangible fixed assels are measured at cost less ac¢umulated depreciation and any accumulated impaimient losses. All costs incurred to bring a tangible fixed asset into its intended working conditbon should be included in the measurement of cost. At each reporting date the Company assesses whether there is any indication of impairnient. If such indication exists. the COVerable amount of the asset is determined to be the higher of its fair value less costs to sell and its value in use. An impaimient bss is recognised where the carryin9 amount exceeds the re¢over8ble amount. Depreciation is charged so as to allocate the cost of tangible red assets less their residual value over their estimated useful lives. Depreciation is provided on the following basis: Computer equlpmant 20% stralght Ilne basls Page 16
ARK CANCER CHARITY (A Company Llmlted by Guarantsè) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 Accountlng pollcles (contlnued) 2.6 Debtors Trade and other debtors are recognised at the Settlement amount after any Irade dlscount offered. Prepayments are valued at the amount prepaid net of any trade discounts due. 2.7 Current asset Invgstments Current assel investrnents include short-tem deposits with a maturity of more Ihan three months from the date of opening of the depostt or slmilar account. 2.8 Cash at bank and In hand Cash at bank and in hand includes cash and short-temi highly Ilquld Investments wlih a short maturfty of three months or less from the date of acquisition or opening of the deposlt or similar account. 2.9 Llabllltles and provlslons Liabilities are recognised when there is an obligation at the Balance Sheet date as a result of a past event, it is probable that a transfer of economic benefrt will be required in settlement, and the amount of the settlement can ba egtimated reliably. Liabilities are re¢ognised at tha amount that th8 Company anticipates it will pay to settle the debt or the amount it has received as advanced payments for the goods or services tt must pn)vide. 2.10 Financial Instruments The Company only has financial &%8ets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initialty recognised at transaction value and subsequently measured at their settlement value with the exception of bank loans which are subsequently measured at amortised cost using the effective interest method. 2.11 Fund accountlng General fvnds arn unrestricted funds which are available for u8e at tho discretion of the Trustees in furtherance of the generel objectives of the C¢)mpany and which have not been destgnated for other purposes. Designated fund8 comprise unrestricted funds that have been set aside by the Trustees for particular purposes. The aim and use of each designated fund is set out in the notes to the finanGial statements. Investment income, gains and losses are allocated to the appropriate fund. Page 17
ARK CANCER CHARITY (A Company Llmltod by Guarant•8) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 Incom• from donatlon8 and legacles Unre8trfcted fund8 2024 Total funds 2024 Donations Legacies Grants 43,738 95,000 550,000 43.736 96,000 660.000 688,736 688,736 Included Sn donatlons18 £8,097 (2023 - £17,540> eBtlm8ted a8 the co8t of 8alartes donat•d. Grants recelvable are from lh8 Greenham Tru8t for the refurbi8hm8nt Costs ol the Oncology Centr8. Unrnsbicted fvnds 2023 Total funds 2023 Donatlon8 L8gacl88 Grants 28, 124 9,291 28,124 9,291 37,415 37,415 Income from charltable actlvltleB Incom• from fundralslng avant8 Unrn8trlctsd funds 2024 Total fund8 2024 Income Irom events 34.817 34,817 Page18
ARK CANCERCHARITY (A Company Umlted by Guarantee NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER2024 Income from charttable acllvltle• (contlnuad) Incomo from fundral8lng •vffits Icontlnued) funds 2023 2023 Inwne from events Xl,075 30,075 Invo•tm•nt Incom• Unrestrlcted funds 2024 Total fvnds 2024 Bank Intere8t receivable 82,6 81266 Unrnstr'cled lunds 2023 Tot81 funds 2023 Bank 5ntere8t receivable 69,541 69,541 Expendlturn on ral8lng funds Costs of ralslng voluntary Incomo Unr•strfcted funds 2024 Total fund8 2024 Event Costs Onllne donatl¢M fee8 Cost of m8rkoting and prlzes 676 2,933 676 1933 3,609 Page 19
ARK CANCER CHARITY (A Company LIMIt by Guarnnteo) NOTES TO THE FINANCIAL STATEPIIENTS FOR THE YEAR ENDED 31 DECEMBER 2024 Expendlture on ralslng funds (contlnuedl Cosls of raising voluntary income (conlinued) Unreslrfcted funds 2023 Total lunds 2023 Online donation fees Costs of marketing and piizes 216 2,398 216 2,398 2.614 2,614 Anatyskn of exponditurn on charltable actm Actlvttles Grant undertaken fundlng of dlrectly adiviti08 2024 2024 Support costs 2024 Total funds 2024 Direcl costs 1.844.398 256,276 33,426 2.134.100 rtak8n funding ol Support costs 2023 Total funds 2023 2023 2023 Direct costs 108,245 10,366 20,476 139.087 Included in support costs Is £8,lJ97 ()23 - £17.540) estimated as the cost of salaries donated. Pago 20
ARK CANCER CHARITY IA Company Llmlted by Guarantse) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 Analysls of oxpenditurn on ch•rftsbl• actlvltla8 (ContInu) Analysls of dlr•ct C08ts Dlrect cost• . Actfvlt188 2024 Total funds 2024 Ralnbow unlt refurbishmont Cts 1,844,398 1,844,398 Dirnct costs- Activitses 2023 Tolal funds 2023 Ranbow unlt refvrbl8hment costs 108,245 108,245 Anaty818 of 8UPPOrt costs Total funds 2024 Total fijnds 2023 Fee818ub8crfptlon8 Mlscellaneous costs Website costs Recharged salary costs Statlonery Telephone Govemance costs 441 661 (34) 487 6,290 1,096 147 8,619 301 11,976 33.426 20,476 Page 21
ARK CANCER CHARrrY (A CTrpany Limlted ty Guarantse) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 Analysis of grnnt8 Grnnts to Instltutlons 2024 Total funds 2024 Grants to Hampshire Hospitals NHS Foundation Trust in supptyl of the Wellbeing Centre 256,276 256.276 Grants to Ins&tuti 2023 Totsl funds 2023 Grants to Hampshire Hospitals NHS Foundation Trust in support of tr Wellbeing Centre 10,366 10,366 Independent examlnots remuneratlon Th8 independent examlnefs remuneration amounts to an independent exIner fee of £3,450 (2023 - £3,270). 10. Tru8tees' remunoratlon and expons During the year, no Trustees receiv•d any remuneratK>n or other benefits (2023- £NIU. During the yw ended 31 December 2024, expenses totalng £147 *re paid directly to 1 Trustee (2023 - £NIL) The expenses incurred were reimbursmwt of purchases on behalf of the charity. Page 22
ARK CANCER CHARITY (A Company Llmlted by Guarantee) NOTES TO THe FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 11. Tanglbl• fflxod a888ts Computer oqulpmont Cost or valuatlon At 1 January 2024 Addltlons 9,669 3,283 At 31 Dnber 2024 12,932 Depreclatlon Al 1 January 2024 Charge for the year 2,659 1,932 At 31 Decemhr 2024 4,691 Not book valuo At 31 December 2024 8,341 At 31 December 2023 7,010 11 Dobtorn 2024 2023 Prepaymenls and accru•d Income 581,676 9,838 Page 23
ARK CANCER CHARITY (A Company Umlted by Guarantee) NOTES TO THE FINANCIAL STATEME18 FOR THE YEAR ENDED 31 DECEMBER 2024 l& Current asset Invoslmonts 2024 2023 Terni deposit accounts 1,000,000 2.058.596 14 Credltor9: Amounts falllng du• wlthln one yaar 2023 Accruals and deferred income 1,805,902 97,458 Page 24
ARK CANCER CHARITY IA Company Llmltod by Guarantse) NOTES TO THE FINANCIAL STATEMEKrs FOR THE YEAR ENDED 31 DECEMBER 2024 15. Stat•m•nt of fund• ststement of fund• - curv•nt y•ar Balance at 31 Trnnsfov• December lnlout 2024 8alance at 1 Janu•ry 2024 Incorne Exp•ndlture Unr•8trlcted fund• De8lgnatsd lund8 Wellbeing cmiplhnentary therapies Wellbeing mental health services Rainbow unit project 366,000 698,000 623.634 1.391.766 1266,2761 328,642 682,000 11.844,398) (129,36n 2.381.389 682,000 12,100.674) 199,285 1,062.000 G•neral fund8 General furKIs 274.6 223,820 (37,0351 (199,286) 262,029 Total Unrestrlcw fun 2,655.918 805,820 (2,137,709) 1.324,029 Page 25
ARK CANCER CHARITY IA Company Llmited by Guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 15. Statement of funds {contlnued) Statement of funds . prlor year Balance al 31 December 2023 Balance at l January 2023 Income Expenditu Unrestrfcted funds D8signatad fund8 Wellbeing complimentary therapies Wellbeing mental heatth seThices Rainbow unlt project 366,000 634,000 1,500,000 366,000 (10,366) 623,634 (108,245) 1,391, 755 2.500.000 (118,611) 2.381.389 Gen•ral fund8 General funds 160.587 137,032 (23,090) 274.529 Total Unrestrlcted funds 2,660,587 137,032 (141,701) 2,655,918 Page 26
ARK CANCER CHARITY (A Company Limited by Guardntee) NOTES TO THE FINANCIAL STATEIAENTS FOR THE YEAR ENDED 31 DECEMBER 2024 16. Summary of funds Summary of funds- current year Balance at 31 Transfers ¢8Mber inlout 2024 Balance at 1 January 2024 Incom• EXndItUrn Designated funds General funds 2W1.389 274.529 582,000 12,100,674 199,286 223.820 (37,035) 1199,285) 1,062.000 262,029 1654918 805,820 12,137.709 1.324.029 Summary of funds- prior year Balance at 31 December 2023 BalarKe at 1 January 2023 InCe Expendilure Designated funds General fund8 2.500,OCYI 160,587 (118,611) 2,381,389 (23,090) 274,529 137,032 2.660.587 137,032 (141,701) 2,655,918 Page 27
ARK CANCER CHARITY (A Company Umlted by Guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 17. Analysls of nat assat8 between funds Anatysls of not assots botwaen funds - currnnt parlod Unrestrlctod funds 2024 Total funds 2024 Tangible fixed assets Current assets Creditors due within one year 8.341 8.341 3,121.590 3.121,690 (1,805,902) 11,805.902) Total 1.324.029 1,324,029 18. Reconclliatlon of net movement In funds to net cash flow from operatlng actlvltles 2024 2023 Net expenditure for the period (as per Slatement of Financial Actiirities) 11.331.890) (4, 670J Adjustments for: Depreciation charges Dividends, interests and rents from inwtments Decreasel(increase) in debtors Increasel(decrease) in creditor3 1,932 182.266) (571.838) 1.708,445 1, 125 (69, 541) (785) (86.329) Net cash used In operatlng actlvltles (275,61n (160,200) 19. Analysls of cash and cash equlvalents 2024 2023 Cash in hand Notice deposits (less than 3 months) Terni deposits (mor& than 1 year) 123,050 1,416,864 1,000,000 159,919 518,013 2,058,596 Total cash and cash aqulvalents 2,539,914 2, 736,528 Page 28
ARK CANCER CHARITY (A Company Llmlted by Guarants•) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER2024 Analysh of changes In net debt At1 January 2024 Cmh flo At31 Dacemb•r 2024 Cash at bank and In hand Tern deposit accounts 677.932 861,982 1,539,914 2.068.696 (1.068,5961 1,000,000 2.736.628 (196,6141 1639,914 21. Operatlng lea•0 commllmonts At 31 December 2024 tho Cunpany Imd commltrnents to make futurg minimumlgase payments under non-cancellable operating leases as foll(M: 2024 2023 Equlpment Not later than 1 year Later than 1 year and not later than S yearn 1.250 1. 133 378 2,383 21 Memb•r8' Ilablllty Each member of the charitable Company undertakes to contribute to tha assets of the Company In the event of it being wound up whlle he18he 18 a mwnber. or within one year after helshe ceases to be mwnber, such amount as may be required, not exc8ading £1 for the debts and liabilities contracted before hel8he ceas89 to bo a member. 23. R•lat¢d party transactlon• Durfng the year a Trustee of the charity had an honorary contract Hampshlre Hospltals NHS Foundatlon Tnml, in forni of salary recharged costs, amounted to £7,450. X Controlllng party Durfng the year, the charity was urKler the control of the Trustea8. Page 29